Adicet Bio, Inc. (NASDAQ:ACET – Get Rating) has been given a consensus recommendation of “Moderate Buy” by the seven ratings firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average 12 month target price […]
Adicet Bio (NASDAQ: ACET) recently received a number of ratings updates from brokerages and research firms: 3/17/2023 – Adicet Bio had its “buy” rating reaffirmed by analysts at JMP Securities. They now have a $19.00 price target on the stock. 3/16/2023 – Adicet Bio is now covered by analysts at StockNews.com. They set a “sell” […]
Adicet Bio (NASDAQ:ACET – Get Rating)‘s stock had its “outperform” rating restated by analysts at Wedbush in a report issued on Thursday, Benzinga reports. They currently have a $30.00 target price on the stock. Wedbush’s price objective suggests a potential upside of 303.77% from the stock’s previous close. Wedbush also issued estimates for Adicet Bio’s […]